AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $136,595 | +5.2% | 5,519 | +20.3% | 0.01% | 0.0% |
| Q2 2023 | $129,904 | +34.7% | 4,587 | +9.2% | 0.01% | +25.0% |
| Q1 2023 | $96,474 | -20.2% | 4,200 | 0.0% | 0.00% | -20.0% |
| Q4 2022 | $120,960 | +2.5% | 4,200 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $118,000 | +26.9% | 4,200 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $93,000 | -23.8% | 4,200 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $122,000 | -11.6% | 4,200 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $138,000 | -34.0% | 4,200 | -7.1% | 0.01% | -37.5% |
| Q3 2021 | $209,000 | -21.4% | 4,521 | -6.4% | 0.01% | -20.0% |
| Q2 2021 | $266,000 | – | 4,830 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |